Nuclear CSPP1 expression defined subtypes of basal-like breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The CSPP1 gene encodes proteins crucial for ciliogenesis and cell division.
• CSPP1 is a candidate oncogene in luminal breast cancer, but its protein expression was unknown.
• Centrosome and microtubule-associated proteins play roles in cell regulation.

Purpose of the Study:

• To investigate CSPP1 protein expression in normal and cancerous breast tissues.
• To correlate CSPP1 expression patterns with molecular and clinical features of breast cancer.
• To explore the potential of CSPP1 as a biomarker for breast cancer subtypes.

Main Methods:

• Examined CSPP1 gene and protein expression in normal mammary tissue, breast cancer cell lines, and patient biopsies.
• Analyzed cell type and epitope-dependent subcellular CSPP1 staining.
• Correlated CSPP1 expression with molecular (gene copy number, mRNA) and clinical parameters.

Main Results:

• A novel nuclear CSPP1 isoform was found exclusively in luminal epithelial cells.
• Cytoplasmic CSPP-L was generally expressed in normal mammary epithelium.
• Nuclear CSPP1 expression in luminal cells correlated with gene copy number and mRNA levels.
• Basal-like carcinomas generally showed lower CSPP1 mRNA expression.
• A subgroup of basal-like carcinomas with nuclear CSPP1 expression exhibited luminal traits and differed in eight-gene expression.
• This eight-gene signature predicted survival differences in an independent cohort.

Conclusions:

• Differential expression of a nuclear CSPP1 isoform identifies biologically and clinically distinct subgroups of basal-like breast carcinoma.
• CSPP1 protein expression patterns can differentiate breast cancer subtypes.
• Nuclear CSPP1 may serve as a biomarker for specific breast cancer classifications.